Resultado da Busca
21 de fev. de 2021 · Brain metastases (BM) from colorectal cancer (CRC) are rare. There is little available information regarding incidence, risk factors, prognostic factors, treatment, and overall survival (OS). In this systematic review we performed a research of the current literature and exposed an average incidence of 2.10%.
- Sophie Müller, Franziska Köhler, Anne Hendricks, Carolin Kastner, Kevin Börner, Johannes Diers, Joha...
- 10.3390/cancers13040900
- 2021
- Cancers (Basel). 2021 Feb; 13(4): 900.
22 de jan. de 2021 · In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metastases. Methods: We identified stage 4 colorectal adenocarcinoma patients with brain metastasis using the National Cancer Database diagnosed between 2010 and 2015.
- Suleyman Yasin Goksu, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Emrah Gumusgoz, David Hsieh, Muhamm...
- 2021
10 de out. de 2022 · To investigate the clinical characteristics, survival, prognostic factors, and treatment of brain metastasis (BM) from colorectal cancer (CRC). Twenty-one patients with BM from CRC were retrospectively reviewed.
- 10.1097/MD.0000000000030273
- 2022/10/10
Background: The purpose of the study was to characterize the rare cohort of patients (pts) with metastatic colorectal cancer (mCRC) and brain metastasis (BM) and to identify prognostic subgroups. Patients and Methods: In collab-oration with the Munich Cancer Registry, pts with mCRC and BM who were diagnosed between 1998 and 2011 were identified.
Brain metastases (BMs) from colorectal cancer (CRC) are unusual; however, an increase in incidence has been reported. The evidence available on the subject is scarce, and a better understanding is warranted.
Brain metastases (BM) from colorectal cancer (CRC) are a rare event. However, the implications for affected patients are severe, and the incidence has been reported to be increasing. For clinicians, knowledge about the characteristics associated with BM is important and could lead to earlier diagnosis and improved survival. Method:
Patients with colorectal lung metastases, especially those young with right-sided CRC, require close imaging surveil- lance of BM. The prognosis of CRC patients with BM and lung metastases is poor, and comprehensive treatment based on
